Cite

    Currow, D. et al. (2020). A randomized, double‐blind, crossover, dose ranging study to determine the optimal dose of oral opioid to treat breakthrough pain for patients with advanced cancer already established on regular opioids. European journal of pain. pp. 983-991. [Online].